NCT01103739 - To Explore The Potential For PF-04531083 To Effect The Blood Concentrations Of Simvastatin And Its Main Acid Metabolite Following Co-Administration Of Both Medications | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Chronic Pain

Interventions

DRUG

PF-04531083

PF-04531083: 100mg to be dosed twice daily as a suspension from Day 2 through Day 14 of the study.

DRUG

simvastatin

Simvastatin: a single 20mg tablet to be given on Days 1 and 14 of the study.

DRUG

PF-04531083

PF-04531083: a dose to be selected depending on results from Cohort 1 to be dosed twice daily as a suspension from Day 2 through Day 14 of the study.

DRUG

simvastatin

Simvastatin: a single 20mg tablet to be given on Days 1 and 14 of the study.

Trial Locations (1)

Pfizer Investigational Site, Brussels